OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
56
Results
Show all
Save search
Copy query
Show results for
Unknown
(39)
Metabolomics
(12)
Proteomics
(2)
Genomics
(2)
Clinical
(1)
Organisms
Streptococcus thermophilus LMD-9
(1)
microbial mat metagenome
(1)
Neoseiulus barkeri
(1)
Synechococcus sp. CC9311
(1)
Vibrio parahaemolyticus RIMD 2210633
(1)
Aspergillus fumigatus var. fumigatus
(1)
Sus scrofa scrofa
(1)
SARS coronavirus Sin3765V
(1)
Aspergillus niger NRRL3
(1)
Acipenser baerii
(1)
NEWT:381198
(1)
Megalopygidae sp. BOLD:AAA3544
(1)
Burkholderia sp. H5.7(2011)
(1)
Polaribacter sp. Q13
(1)
Pseudomonas syringae pv. tomato
(1)
Tenacibaculum dicentrarchi
(1)
Ornithodoros sp. AJM-2011b
(1)
Papio anubis anubis
(1)
Capra
(1)
Lutjanidae
(1)
Serranidae
(1)
Labridae
(1)
Penaeus
(1)
Phasianidae sp.
(1)
Chloroflexota
(1)
Human alphaherpesvirus 3
(1)
Mesotaenium endlicherianum
(1)
Robinia pseudoacacia
(1)
Zygnema circumcarinatum
(1)
Nostoc punctiforme PCC 73102
(1)
Organisms
Homo sapiens
(1)
Repository
MetaboLights
(12)
ENA
(2)
MassIVE
(1)
pride
(1)
Tissue
Lymph node of lower limb
(1)
Non-Hodgkin lymphoma cell line
(1)
Lymph node of upper limb
(1)
Lymph node
(1)
Disease
Neoplasms
(1)
Non-Hodgkin lymphoma
(1)
Technology Type
Mass spectrometry assay
(9)
Mass spectrometry
(3)
Proteogenomics
(1)
Mass Spectrometry
(1)
Instrument Platform
Liquid Chromatography MS - positive - reverse-phase
(6)
Liquid Chromatography MS - negative - reverse-phase
(6)
Liquid Chromatography MS - alternating - reverse-phase
(2)
Liquid Chromatography MS - negative - hilic
(2)
Liquid Chromatography MS - positive - hilic
(2)
Liquid Chromatography MS - positive - reverse phase
(2)
Q Exactive HF
(1)
Liquid Chromatography MS - negative - reverse phase
(1)
Publication Date
2026
(11)
2024
(1)
2022
(1)
2025
(1)
CHEBI ID
CHEBI:178475
(2)
CHEBI:192655
(2)
CHEBI:192613
(2)
CHEBI:192588
(2)
CHEBI:145120
(2)
CHEBI:183780
(2)
CHEBI:173349
(2)
CHEBI:183368
(2)
CHEBI:44602
(2)
CHEBI:75757
(2)
CHEBI:31345
(2)
CHEBI:139132
(2)
CHEBI:183484
(2)
CHEBI:39236
(2)
CHEBI:38108
(2)
CHEBI:190628
(2)
CHEBI:91272
(2)
CHEBI:182644
(2)
CHEBI:183494
(2)
CHEBI:192584
(2)
CHEBI:181001
(2)
CHEBI:183721
(2)
CHEBI:183779
(2)
CHEBI:183455
(2)
CHEBI:3086
(2)
CHEBI:192564
(2)
CHEBI:190560
(2)
CHEBI:28934
(2)
CHEBI:7865
(2)
CHEBI:65136
(2)
Metabolite Name
LNH
(12)
Hypoxanthine
(11)
5-Methylcytosine
(10)
Styrene
(10)
L-Kynurenine
(10)
Acetylcholine
(10)
Indole
(10)
Choline
(10)
Cytidine
(10)
3-amino-2-phenyl-2H-pyrazolo[4,3-c]pyridine-4,6-diol
(9)
Thymine
(9)
Phe-Phe
(9)
N6-Succinyl Adenosine
(9)
O-Cresol
(9)
Isoproterenol
(9)
(5E)-7-methylidene-10-oxo-4-(propan-2-yl)undec-5-enoic acid
(9)
3-hydroxy-2-octylpentanedioic acid
(9)
3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione
(9)
4-oxododecanedioic acid
(9)
P-Mentha-1,3,8-triene
(9)
Pyridoxamine
(9)
16-Heptadecyne-1,2,4-triol
(9)
6-(3-hydroxybutan-2-yl)-5-(hydroxymethyl)-4-methoxy-2H-pyran-2-one
(9)
5,8-dihydroxy-10-methyl-5,8,9,10-tetrahydro-2H-oxecin-2-one
(9)
2,3-dihydroxypropyl 12-methyltridecanoate
(9)
(12Z)-9,10,11-trihydroxyoctadec-12-enoic acid
(9)
Isoquinoline
(9)
D-(+)-Proline
(9)
N-Acetylneuraminic acid
(9)
Oleamide
(9)
First Public Date
2025
(1)
2021
(1)
Study status
Completed
(1)
Study type
Interventional
(1)
Release Date
2025
(6)
2023
(6)
2021
(6)
2022
(5)
2019
(4)
2024
(3)
2020
(2)
2018
(2)
2017
(2)
2013
(1)
2010
(1)
2009
(1)
Lab affiliation
UIMGH, UMAE HP, Instituto Mexicano del Seguro Social, Proteomis Laboratory
(1)
Location
Poland
(1)
Spain
(1)
United States
(1)
Tags
xref:PubMed:40920867
(1)
Keyword
Trail Receptor
(1)
Tumor Necrosis Factor
(1)
Insulin-like Growth Factor
(1)
Monoclonal Antibody
(1)
AMG 479
(1)
Ganitumab
(1)
Conatumumab
(1)
AMG 655
(1)
Modified FOLFOX6
(1)
MFOLFOX6
(1)
Apoptosis
(1)
FOLFOX
(1)
Leucovorin
(1)
Bevacizumab
(1)
Fluorouracil
(1)
Oxaliplatin
(1)
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
Cellulosic ethanol production from AFEX-treated corn stover using Saccharomyces cerevisiae 424A(LNH-ST).
Not available
S-EPMC2635794
|
biostudies-literature
Cite
TMT-based Quantification LNH treated with incomptine A
Summary In this project, 2717 proteins were identified. The fold-change cutoff was set when proteins with quantitative ratios above 1.5 or below 1/1.5 are deemed significant.
ORGANISM(S):
Mus musculus (Mouse)
2025-02-27
|
PXD060392
|
Pride
Lnh
Balbc mice
Incomptine a
Cite
Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte.
Not available
S-EPMC2951853
|
biostudies-literature
Cite
Volumetric quantification of absolute local normalized helicity in patients with bicuspid aortic valve and aortic dilatation.
Not available
S-EPMC5316512
|
biostudies-literature
Cite
D1-plus vs D2 nodal dissection in gastric cancer: a propensity score matched comparison and review of published literature.
Not available
S-EPMC7285465
|
biostudies-literature
Cite
Chemoenzymatic Synthesis of Asymmetrically Branched Human Milk Oligosaccharide Lacto-
N
-Hexaose.
Not available
S-EPMC9194828
|
biostudies-literature
Cite
Chemical Synthesis of Human Milk Oligosaccharides: Lacto-
N
-hexaose Galβ1→3GlcNAcβ1→3 [Galβ1→4GlcNAcβ1→6] Galβ1→4Glc.
Not available
S-EPMC8114087
|
biostudies-literature
Cite
Uncertainty About the Size of the Unauthorized Foreign-Born Population in the United States.
Not available
S-EPMC9107075
|
biostudies-literature
Cite
The Association Between Maternal Psychological Health and Human Milk Oligosaccharide Composition.
Not available
S-EPMC11807868
|
biostudies-literature
Cite
Phenotypic selection of a wild Saccharomyces cerevisiae strain for simultaneous saccharification and co-fermentation of AFEX™ pretreated corn stover.
Not available
S-EPMC3729497
|
biostudies-literature
Cite
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
